Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Elevating CKD-aP Care: New Frontier
CKD-aP Treatment Tool Kit
Kappa-Opioid Settings: Real-World Evidence Insights
The Patient-Clinician Connection in Managing CKD-aP
Is CKD-aP Hiding in Your Dialysis Center?
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Patrick Rossignol, MD, PhD
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
Difelikefalin: Managing CKD-aP for Improved Quality of Life
Jörg Latus, MD